Patent 7601534 was granted and assigned to National Center for Scientific Research on October, 2009 by the United States Patent and Trademark Office.
The use of a cellular development inhibitor in a controlled manner in order to maintain an undifferentiated stem cell state, especially one of human stem cells, whereby cell division is permitted.